Inspire Medical Systems (INSP) Stock: Buy, Sell, or Hold?
INSP - Inspire Medical Systems, Inc.
$71.07
-0.27 (-0.38%)
âŧ
5d:
+4.41%
30d:
-0.32%
90d:
+39.87%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 02, 2026
10d
Get Alerted When INSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: INSP is fairly priced but lacks strong directional signals. At 6.5% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: INSP is fairly priced but lacks strong directional signals. At 6.5% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$71.71
Based on 13.5% avg growth
INTRINSIC VALUE TODAY
$44.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSP is currently trading at $71.07, which is considered fair relative to its 30-day fair value range of $68.34 to $73.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 46.3) compared to its historical average (38.3). At these levels, the market is pricing in 6.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INSP is in a strong uptrend. The price is approaching resistance at $72.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INSP is in a strong uptrend. The price is approaching resistance at $72.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$68.34 -
$73.21
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
Protect Your Profits
Holding INSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($68.00)
- NEUTRAL: PE elevated vs history but 6.5% growth expectation is conservative given 308% recent growth
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$68.34 -
$73.21
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$6.41
(9.0%)
Support & Resistance Levels
Support Level
$66.07
Resistance Level
$72.50
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
46.26
Wall Street Target
$68.00
(-4.3%)
Revenue Growth (YoY)
-7.6%
Earnings Growth (YoY)
308.4%
Profit Margin
15.0%
Valuation Premium vs History
+6.5% premium
PE vs Historical
46.3 vs 38.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$75.69
(+7%)
2-Year Target
$80.61
(+13%)
3-Year Target
$85.85
(+21%)
3-Yr Target (if PE normalizes)
(PE: 46â38)
PE COMPRESSION
$71.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 46.3, Growth: 23.0%)
$132.09
(+86%)
Base:
(SPY PE: 19.9, Growth: 23.0%)
$56.71
(-20%)
Bear:
(PE: 16.9, Growth: 23.0%)
$48.21
(-32%)
đ
Valuation based on Current Earnings
Trailing PE: 15.71 | Current EPS (TTM): $4.54
Bull Case
$39.24
(-45%)
Analyst growth -50.0%, PE expands to 17.3
Base Case
$35.67
(-50%)
Market implied -50.0%, PE stable at 15.7
Bear Case
$48.51
(-32%)
Severe decline -20.0%, PE contracts to 13.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 5:30 AM ET
Data refreshes hourly during market hours. Next update: 6:30 AM
Data refreshes hourly during market hours. Next update: 6:30 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
Advanced INSP Option Strategies
Professional options setups generated by AI based on today's INSP price and gamma walls.
